Neuroblastoma cells, like many cancer cells, have an overactivated AKT/mTOR signaling pathway [13], suggesting involvement in drug- and radiation-resistance mechanisms [11, 14, 15]. This evidence concerns the gene AKT1 and neuroblastoma.